Dr. Patrick Tenbrink, M.D.
What this data tells you about Dr. Tenbrink
Dr. Patrick Tenbrink is an urology physician in Palm Beach Gardens, FL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Tenbrink performed 8,441 Medicare services across 2,777 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tenbrink received a total of $5,543 from 33 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tenbrink is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 4,100 | $2 | $4 |
| Office visit, established patient (20-29 min) | 709 | $62 | $125 |
| Bladder ultrasound after voiding | 682 | $8 | $100 |
| Manual urinalysis test with examination using microscope, non-automated | 606 | $4 | $15 |
| Office visit, established patient (30-39 min) | 483 | $89 | $175 |
| Urinalysis, manual | 344 | $3 | $5 |
| PSA test (prostate cancer screening) | 140 | $18 | $68 |
| Limited ultrasound scan behind abdominal cavity | 137 | $41 | $200 |
| New patient office visit (30-44 min) | 132 | $78 | $180 |
| New patient office visit (45-59 min) | 129 | $113 | $240 |
| Blood draw (venipuncture) | 123 | $8 | $11 |
| Diagnostic exam of bladder and urethra using an endoscope | 115 | $168 | $500 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 96 | $38 | $1,300 |
| Hospital follow-up visit, moderate complexity | 86 | $59 | $150 |
| Instillation of anti-cancer drug into bladder | 80 | $56 | $425 |
| Office visit, established patient (10-19 min) | 66 | $35 | $100 |
| Initial hospital admission, high complexity | 54 | $129 | $300 |
| Ultrasound scan of pelvic region through rectum | 47 | $100 | $245 |
| Initial hospital admission, moderate complexity | 47 | $87 | $253 |
| Electronic assessment of bladder emptying | 44 | $5 | $225 |
| Insertion of stent in ureter using an endoscope | 33 | $113 | $1,576 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 31 | $311 | $1,125 |
| Psa (prostate specific antigen) measurement, free | 30 | $18 | $68 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 25 | $157 | $1,750 |
| Office visit, established patient, complex (40-54 min) | 23 | $132 | $200 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $67 | $100 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 17 | $197 | $1,400 |
| Simple insertion of temporary bladder tube | 16 | $44 | $200 |
| Biopsy of prostate gland | 13 | $98 | $400 |
| Ultrasonic guidance for needle placement | 13 | $23 | $300 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tenbrink is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tenbrink experienced with bcg treatment for bladder cancer?
Does Dr. Tenbrink receive payments from pharmaceutical companies?
How do Dr. Tenbrink's costs compare to other urology physicians in Palm Beach Gardens?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology